To treat or not to treat? : dilemmas when deciding on antineoplastic treatment in patients with far advanced cancers

Article indépendant

PAIVA, Carlos Eduardo | D'ALMEIDA PRETO, Daniel | DE LIMA, Crislaine | SAKAMOTO RIBEIRO PAIVA, Bianca

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative review, we will explore the decision-making process for patients with advanced cancers and provide insights on how to approach this complex task, while didactically dividing the oncologist's assessments according to a mnemonic rule of the ABCDE of therapeutic decision-making. Part A (advanced cancer) recalls that the rule is to be used specifically for advanced cancers. Parts B (potential benefits) and C (clinical conditions and risks) represents the traditional risk vs benefit scale. In Part D, we discuss ways to identify and understand patients' desires, values, preferences, and beliefs. The prognostic estimation, from Part E, may function as an "adjust" for the antineoplastic treatment decision-making. Treatment decisions need to be conducted by skilled oncologists, in a patient-centered care, aiming to promote valuable oncology with lower rates of aggressive care.

http://dx.doi.org/10.1177/10732748231176639

Voir la revue «Cancer control, 30»

Autres numéros de la revue «Cancer control»

Consulter en ligne

Suggestions

Du même auteur

To treat or not to treat? : dilemmas when dec...

Article | PAIVA, Carlos Eduardo | Cancer control | vol.30

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative rev...

To treat or not to treat? : dilemmas when dec...

Article indépendant | PAIVA, Carlos Eduardo | Cancer control | vol.30

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative rev...

Pharmacologic management of end-of-life delir...

Article indépendant | HUI, David | Cancers | n°11 | vol.16

End-of-life delirium affects a vast majority of patients before death. It is highly distressing and often associated with restlessness or agitation. Unlike delirium in other settings, it is considered irreversible, and non-pharmac...

De la même série

Patients' trajectory with lung cancer from tr...

Article indépendant | OGURA, Yuri | Cancer control | vol.31

INTRODUCTION: This study aimed to describe the course of patients with lung cancer from treatment initiation to end-of-life. METHODS: This retrospective cohort study used Claims Data from the National Health Insurance and Advanced...

Advance care planning with Black women with b...

Article indépendant | TAN, Marcia M. | Cancer control | vol.30

BACKGROUND: Despite the importance of advance care planning (ACP), a process that optimizes future medical treatment and end-of-life care, for at-risk populations, rates of patient-provider ACP conversations are extremely low amon...

To treat or not to treat? : dilemmas when dec...

Article indépendant | PAIVA, Carlos Eduardo | Cancer control | vol.30

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative rev...

Survival prediction in home hospice care pati...

Article indépendant | ZENG, Yicheng | Cancer control | vol.29

Purpose: The aim of the present study was to develop a nomogram for prognostic prediction of patients with lung cancer in hospice. Methods: The data was collected from 1106 lung cancer patients in hospice between January 2008 and ...

Intensity of care, expenditure, and place of ...

Article indépendant | TANGUY-MELAC, Audrey | Cancer control | n°1 | vol.27

Health care utilization of women with breast cancer (BC) during the last year of life, together with the causes and place of death and associated expenditure have been poorly described. Women treated for BC (2014-2015) with BC as ...

Chargement des enrichissements...